- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02139449
Prospective Study on Prognosis of Cardiac Resynchronized Therapy (CRT), Implantable Cardioverter Defibrillator (ICD) Implantation in Patients With Congestive Heart Failure (CHF)
Study Overview
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Boyoung Joung, MD, PhD
- Phone Number: 82-2-2228-8460
- Email: cby6908@yuhs.ac
Study Locations
-
-
-
Seoul, Korea, Republic of, 120-752
- Recruiting
- Severance Hospital
-
Contact:
- Boyoung Joung, MD, PhD
- Phone Number: 82-2-2228-8460
- Email: cby6908@yuhs.ac
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age >=18
- LV ejection fraction <40% or Clinical HF Symptom with (LV ejection fraction >40%)
- medication for at least 3month
Exclusion Criteria:
1. patient who refuse to enroll the study
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
ICD/CRT registry
ICD / CRTregistry in Severance or Ewha Womans University Medical Center
|
cardiac resynchronized therapy (CRT), implantable cardioverter defibrillator (ICD) implantation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Transthoracic echocardiography (TTE)
Time Frame: before enrollment
|
before enrollment
|
|
|
Transthoracic echocardiography (TTE)
Time Frame: 12 month later afer enrollment
|
12 month later afer enrollment
|
|
|
EKG
Time Frame: before enrollment
|
for Ventricular arrhythmia events
|
before enrollment
|
|
EKG
Time Frame: 1 month later after enrollment
|
for Ventricular arrhythmia events
|
1 month later after enrollment
|
|
EKG
Time Frame: 6 month later after enrollment
|
for Ventricular arrhythmia events
|
6 month later after enrollment
|
|
EKG
Time Frame: 12 month later after enrollment
|
for Ventricular arrhythmia events
|
12 month later after enrollment
|
|
NYHA(New York Heart Association) evaluation
Time Frame: before enrollment
|
For functional capacity - The New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina. |
before enrollment
|
|
NYHA(New York Heart Association) evaluation
Time Frame: 1 month later after enrollment
|
For functional capacity - The New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina. |
1 month later after enrollment
|
|
NYHA(New York Heart Association) evaluation
Time Frame: 6 month later after enrollment
|
For functional capacity - The New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina. |
6 month later after enrollment
|
|
NYHA(New York Heart Association) evaluation
Time Frame: 12 month later after enrollment
|
For functional capacity - The New York Heart Association (NYHA) Functional Classification provides a simple way of classifying the extent of heart failure. It places patients in one of four categories based on how much they are limited during physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and/or angina. |
12 month later after enrollment
|
|
6 minute walking test
Time Frame: before enrollment
|
for functional capacity
|
before enrollment
|
|
6 minute walking test
Time Frame: 12 month later afer enrollment
|
for functional capacity
|
12 month later afer enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Questionnaire on Quality of Life(QOL) : EQ-5D-3L (Optional)
Time Frame: before enrollment
|
EQ-5D-3L is the scale used in the health state description part was three-level; having no problems, having some or moderate problems, being unable to do/having extreme problems.
Rated level can be coded as a number 1, 2, or 3, which indicates having no problems for 1, having some problems for 2, and having extreme problems for 3.
As a result, a person's health status can be defined by a 5-digit number, ranging from 11111 (having no problems in all dimensions) to 33333 (having extreme problems in all dimensions).
|
before enrollment
|
|
Questionnaire on Quality of Life(QOL) : EQ-5D-3L (Optional)
Time Frame: 12 month later afer enrollment
|
EQ-5D-3L is the scale used in the health state description part was three-level; having no problems, having some or moderate problems, being unable to do/having extreme problems.
Rated level can be coded as a number 1, 2, or 3, which indicates having no problems for 1, having some problems for 2, and having extreme problems for 3.
As a result, a person's health status can be defined by a 5-digit number, ranging from 11111 (having no problems in all dimensions) to 33333 (having extreme problems in all dimensions).
|
12 month later afer enrollment
|
|
Cardiac MRI or Cardiac CT
Time Frame: before enrollment
|
before enrollment
|
|
|
Cardiac MRI or Cardiac CT
Time Frame: 12 month later afer enrollment
|
12 month later afer enrollment
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4-2014-0098
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Congestive Heart Failure
-
Indiana UniversityRecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)United States
-
Adnan Kastrati, MDBiotronik SE & Co. KGCompleted
-
Signature Medical, Inc.WithdrawnHeart Failure,Congestive
-
Nihon KohdenTerminatedHeart Failure,CongestiveUnited States
-
ELA Medical, Inc.Approved for marketing
-
Abbott Medical DevicesCompletedCongestive Heart Failure TreatedItaly
-
Echosense Ltd.Terminated
-
Echosense Ltd.WithdrawnCongestive Heart Failure (CHF)United States
-
Corthera, Inc.(formerly BAS Medical, Inc.), a member...TerminatedCongestive Heart Failure (CHF)Russian Federation
-
Meir Medical CenterUnknown
Clinical Trials on ICD/CRT
-
Shanghai Zhongshan HospitalRecruitingHeart Failure, Systolic | Sudden Cardiac DeathChina
-
Abbott Medical DevicesCompleted
-
Biotronik Japan, Inc.CompletedHeart Failure | Arrhythmias, CardiacJapan
-
Abbott Medical DevicesCompletedSudden Cardiac DeathUnited States
-
LivaNovaCompletedSleep ApnoeaFrance, Italy, Germany, Greece
-
Prof. Dr. med. Ingo EitelDeutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)RecruitingNon-ischemic Dilated CardiomyopathyGermany
-
Boston Scientific CorporationGuidant CorporationCompleted
-
Boston Scientific CorporationICON Clinical ResearchCompletedHeart Failure | Arrhythmias, Cardiac | Sudden Cardiac DeathJapan
-
Medtronic Cardiac Rhythm and Heart FailureCompletedHeart Failure | Ventricular Dysfunction | TachyarrhythmiasUnited States, Netherlands, Colombia, South Africa, Japan, Israel, Spain, Canada, United Kingdom, Germany, Slovenia, Sweden, Saudi Arabia, Switzerland, Malaysia, Austria, Czechia, Denmark, India, Italy, United Arab Emirates
-
Biotronik Australia Pty Ltd.Biotronik SE & Co. KGActive, not recruitingHeart Failure | TachycardiaAustralia